Electroconvulsive therapy in a man with autism experiencing severe depression, catatonia, and self-injury

Journal of ECT

Volumn 26, Issue 1, 2010, Pages 70-73

  Wachtel, Lee Elizabeth ^a   Griffin, Merrie ^b   Reti, Irving Michael ^b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Catatonia; Depression; ECT; Self injury

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CLONIDINE; DULOXETINE; FLUMAZENIL; FLUOXETINE; FLUVOXAMINE; GUANFACINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM CARBONATE; LORAZEPAM; METHOHEXITAL; OLANZAPINE; OXCARBAZEPINE; PHENOBARBITAL; PROPRANOLOL; QUETIAPINE; RILUZOLE; RISPERIDONE; SUXAMETHONIUM; VALPROIC ACID; ZIPRASIDONE;

ADULT; AGGRESSION; AKATHISIA; ANAMNESIS; ANESTHESIA INDUCTION; ANXIETY; ARTICLE; AUTISM; AUTOMUTILATION; BODY POSTURE; CALLOSITY; CASE REPORT; CATATONIA; CLINICAL EVALUATION; CREATINE KINASE BLOOD LEVEL; CRYING; DELIRIUM; DEPRESSION; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; DISRUPTIVE BEHAVIOR; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSTONIA; ECHOLALIA; ELECTROCONVULSIVE THERAPY; ELECTROCUTION; ELECTROENCEPHALOGRAM; EMERGENCY WARD; ENZYME BLOOD LEVEL; EVENING DOSAGE; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; FACE INJURY; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HUMAN; HYPERSOMNIA; IRRITABILITY; LABORATORY TEST; LEUKOCYTE COUNT; MAINTENANCE THERAPY; MALE; MEDICAL STAFF; MENTAL DEFICIENCY; MENTAL INSTABILITY; MORNING DOSAGE; MUSCLE RELAXATION; NEUROLEPTIC MALIGNANT SYNDROME; PATIENT SAFETY; PATIENT TRANSPORT; PSYCHIATRIC DEPARTMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOSOCIAL WITHDRAWAL; REMISSION; RESTLESSNESS; SCAR FORMATION; SIDE EFFECT; SUICIDE ATTEMPT; SYMPTOM; WEANING;

AUTISTIC DISORDER; CATATONIA; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; MENTAL RETARDATION; PSYCHOMOTOR AGITATION; PSYCHOTROPIC DRUGS; SELF-INJURIOUS BEHAVIOR; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 77649305329     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181a744ec     Document Type: Article

References (38)

1. Rutter M, Graham P, Yule W. A neuropsychiatric study in childhood. Clin Dev Med. 1970;35-36.
2. Colucci G, Pellicciotta A, Buono S, et al. The Rorschach Egocentricity Index in subjects with intellectual disability: a study on the incidence of different psychological pathologies. J Intellect Disabil Res. 1998; 42(5):354-359.
3. Kishore MT, Nizamie A, Nizamie SH, et al. Psychiatric diagnosis in persons with intellectual disability in India. J Intellect Disabil Res. 2004;48(1):19-24.
4. Rutter M, Tizard J, Yule W, et al. Research report: Isle of Wight studies, 1964-1974. Psychol Med. 1976;6:313-332.
5. White P, Chant D, Edwards N, et al. Prevalence of intellectual disability and comorbid mental illness in an Australian community. Aust N Z J Psychiatry. 2005;39:395-400.
6. Reiss S. Assessment of psychopathology in persons with mental retardation. Psychopathology of the Mentally Retarded. Needham, MA: Allyn and Bacon; 1993.
7. American Association of Mental Retardation. Treatment of psychiatric and behavioral problems in mental retardation. Am J Ment Retard. 2000;105:165-188.
8. Fink M. Electroshock: Healing of Mental Illness. London, UK: Oxford University Press; 1999.
9. Fink M, Taylor MA. Catatonia: a Clinician's Guide to Diagnosis and Treatment. London, UK: Cambridge University Press; 2003.
10. Caroff SN, Mann SC, Francis A, et al. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, Inc; 2004.
11. Hawkins JM, Archer KJ, Strakowski SM, et al. Somatic treatment of catatonia. Int J Psychiatry Med. 1995;25(4):345-369.
12. Bates WJ, Smeltzer DJ. Electroconvulsive treatment of psychotic self-injurious behavior in a patient with severe mental retardation. Am J Psychiatry. 1982;139(10):1355-1356.
13. Bebchuk JM, Barnhill J, Dawkins K. ECT and mental retardation. Am J Psychiatry. 1996;153:1231.
14. Friedlander RI, Solomons K. ECT: use in individuals with mental retardation. J ECT. 2002;18:38-42.
15. Fink M, Taylor M. Electroconvulsive therapy. Evidence and challenges. JAMA. 2007;298:330-332.
16. Kellner CH, Fink M, Knapp R, et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry. 2005;162(5):977-982.
17. Aziz M, Maixner D, Deqardo J, et al. ECT and mental retardation: a review and case report. J ECT. 2001;17:149-152.
18. Reinblatt S, Rifkin A, Freeman J. The efficacy of ECT in adults with mental retardation experiencing psychiatric disorders. J ECT. 2004; 20:208-212.
19. Thuppal M, Fink M. Electroconvulsive therapy and mental retardation. J ECT. 1999;15:140-149.
20. Dhossche D, Shah A, Wing L. Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. Int Rev Neurobiol. 2006;72:267-284.
21. Fink M, Taylor M, Ghaziuddin N. Catatonia in autistic spectrum disorders: a medical treatment algorithm. Int Rev Neurobiol. 2006;72: 233-244.
22. Ghaziuddin M, Quinlan P, Ghaziuddin N. Catatonia in autism: a distinct subtype? J Intellect Disabil Res. 2005;49:102-105.
23. Wachtel L, Kahng S, Dhossche D, et al. Electroconvulsive therapy for catatonia in an autistic girl. Am J Psychiatry. 2008;165: 329-333.
24. Zaw F, Bates G, Murali V, et al. Catatonia, autism, and ECT. Dev Med Child Neurol. 1999;41:843-845.
25. Wachtel L, Contrucci-Kuhn SA, Griffin M, et al. ECT for self-injury in an autistic boy. Eur Child Adolesc Psychiatry. 2009;epub ahead of print.
26. Black D, Wilcox J, Stewart M. The use of ECT in children: case report. J Clin Psychiatry. 1985;46:98-99.
27. Carr V, Dorrington C, Schrader G, et al. The use of ECT for mania in childhood bipolar disorder. Br J Psychiatry. 1983;143:411-415.
28. Chung A, Varghese J. Treatment of catatonia with electroconvulsive therapy in an 11-year-old girl. Aust N Z J Psychiatry. 2008;42:251-253.
29. Cizadlo B, Wheaton A. Case study: ECT treatment of a young girl with catatonia. J Am Acad Child Adolesc Psychiatry. 1995;34:332-335.
30. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry. 2000;176:357-362.
31. Billstedt E, Gilberg C, Gilberg C. Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord. 2005;35: 351-360. (Pubitemid 41125973)
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
33. Bush G, Fink M, Petrides G, et al. Catatonia: I: Rating scale and standardized examination. Acta Psychiatr Scand. 1996;93:129-136.
34. Friedlander R, Lazar S, Klancnik J. Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities. Can J Psychiatry. 2001;46:741-745.
35. Pittenger C, Coric V, Banasr M, et al. Riluzole in the treatment of mood and anxiety disorders. CNS Drugs. 2008;22(9):761-786.
36. Mathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008;33: 2080-2092.
37. Zarate CA, Quiroz JA, Singh JB, et al. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry. 2005;57: 430-432.
38. Sasso DA, Kalanithi PSA, Trueblood KV, et al. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors. J Clin Psychopharmacol. 2006; 26(6):685-587.